Business | Monday December 23, 2013
Torrent Pharmaceuticals, which has agreed to acquire the branded formulation business of Elder Pharmaceuticals in India and Nepal for Rs 2,000 crore, is seeking shareholders' approval to increase its borrowing limits to Rs 5,000 crore.
www.ndtv.com/business